Correlation between lung cancer and the HHIP polymorphisms of chronic obstructive pulmonary disease (COPD) in the Chinese Han population.
Journal
Genes and immunity
ISSN: 1476-5470
Titre abrégé: Genes Immun
Pays: England
ID NLM: 100953417
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
11
12
2017
accepted:
17
04
2018
revised:
10
04
2018
pubmed:
20
6
2018
medline:
21
5
2019
entrez:
20
6
2018
Statut:
ppublish
Résumé
To further investigate the relationship between lung cancer and hedgehog interacting protein (HHIP) polymorphisms of chronic obstructive pulmonary disease (COPD) patients, we conducted a case-control study in a Chinese Han population. Six HHIP SNPs with minor allele frequencies >5% (rs1489758, rs1489759, rs10519717, rs13131837, rs1492820, and rs7689420) were analyzed in 1,017 COPD patients (767 males and 246 females) and 430 non-COPD patients. Using logistic regression analysis, we found that rs7689420 was significantly associated with lung cancer in COPD patients in the Chinese Han population (P < 0.001). The recessive allele of rs7689420 was associated with the occurrence of lung cancer in all COPD patients (odds ratios [OR] of 0.609 and 0.424 for the CT and TT genotypes, respectively) as well as in serious COPD patients (OR of 0.403 and 0.305 for CT and TT, respectively). Additionally, rs1489759 and rs3131837 were associated with lung cancer in various genetic models. rs1489758, rs1489759, and rs10519717 were also associated with lung cancer in serious COPD patients. However, none of the SNPs were significantly associated with lung cancer in mild COPD patients or healthy subjects. Therefore, the HHIP SNPs of COPD patients likely play a role in lung cancer pathology in the Chinese Han population.
Identifiants
pubmed: 29915314
doi: 10.1038/s41435-018-0033-0
pii: 10.1038/s41435-018-0033-0
doi:
Substances chimiques
Carrier Proteins
0
HHIP protein, human
0
Membrane Glycoproteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
273-280Références
Byers T, Wender RC, Jemal A, Baskies AM, Ward EE, Brawley OW. The American Cancer Society challenge goal to reduce US cancer mortality by 50% between 1990 and 2015: results and reflections. CA Cancer J Clin. 2016;66:359–69.
doi: 10.3322/caac.21348
Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet. 2007;370:741–50.
doi: 10.1016/S0140-6736(07)61377-4
López-Campos JL, Ruiz-Ramos M, Soriano JB. Mortality trends in chronic obstructive pulmonary disease in Europe, 1994–2010: a joinpoint regression analysis. Lancet Respir Med. 2014;2:54–62.
doi: 10.1016/S2213-2600(13)70232-7
Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765–73.
doi: 10.1016/S0140-6736(07)61380-4
Salvi S. The silent epidemic of COPD in Africa. Lancet Glob Health. 2015;3:e6–e7.
doi: 10.1016/S2214-109X(14)70359-6
Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34:380–6.
doi: 10.1183/09031936.00144208
Hardin M, Silverman EK. Chronic obstructive pulmonary disease genetics: a review of the past and a look into the future. Chronic Obstr Pulm Dis. 2014;1:33–46.
pubmed: 28848809
pmcid: 5559139
Yin P, Jiang CQ, Cheng KK, Lam TH, Lam KH, Miller MR, et al. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet. 2007;370:751–7.
doi: 10.1016/S0140-6736(07)61378-6
Rooney C, Sethi T. The epithelial cell and lung cancer: the link between chronic obstructive pulmonary disease and lung cancer. Respiration. 2011;81:89–104.
doi: 10.1159/000323946
Huang WC, Tsai YH, Wei YF, Kuo PH, Tao CW, Cheng SL, et al. Wheezing, a significant clinical phenotype of COPD: experience from the Taiwan Obstructive Lung Disease Study. Int J Chron Obstruct Pulmon Dis. 2015;10:2121–6.
doi: 10.2147/COPD.S92062
Lamontagne M, Couture C, Postma DS, Timens W, Sin DD, Pare PD, et al. Refining susceptibility loci of chronic obstructive pulmonary disease with lung eqtls. PLoS One. 2013;8:e70220.
doi: 10.1371/journal.pone.0070220
Young RP, Hopkins RJ, Whittington CF, Hay BA, Epton MJ, Gamble GD. Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPD. PLoS One. 2011;6:e16476.
doi: 10.1371/journal.pone.0016476
Young RP, Whittington CF, Hopkins RJ, Hay BA, Epton MJ, Black PN, et al. Chromosome 4q31 locus in COPD is also associated with lung cancer. Eur Respir J. 2010;36:1375–82.
doi: 10.1183/09031936.00033310
Wang B, Zhou H, Yang J, Xiao J, Liang B, Li D, et al. Association of HHIP polymorphisms with COPD and COPD-related phenotypes in a Chinese Han population. Gene. 2013;531:101–5.
doi: 10.1016/j.gene.2013.08.069
Olsen CL, Hsu PP, Glienke J, Rubanyi GM, Brooks AR. Hedgehog-interacting protein is highly expressed in endothelial cells but down-regulated during angiogenesis and in several human tumors. BMC Cancer. 2004;4:43.
doi: 10.1186/1471-2407-4-43
Chuang PT, Kawcak T, McMahon AP. Feedback control of mammalian Hedgehog signaling by the Hedgehog-binding protein, Hip1, modulates Fgf signaling during branching morphogenesis of the lung. Genes Dev. 2003;17:342–7.
doi: 10.1101/gad.1026303
Chen W, Tang T, Eastham-Anderson J, Dunlap D, Alicke B, Nannini M, et al. Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells. Proc Natl Acad Sci USA. 2011;108:9589–94.
doi: 10.1073/pnas.1017945108
Agrawal V, Kim DY, Kwon YG. Hhip regulates tumor-stroma-mediated upregulation of tumor angiogenesis. Exp Mol Med. 2017;49:e289.
doi: 10.1038/emm.2016.139
Pasca di Magliano M, Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer. 2003;3:903–11.
doi: 10.1038/nrc1229
Chen MH, Wilson CW, Chuang PT. SnapShot: hedgehog signaling pathway. Cell. 2007;130:386.
doi: 10.1016/j.cell.2007.07.017
Chi S, Huang S, Li C, Zhang X, He N, Bhutani MS, et al. Activation of the hedgehog pathway in a subset of lung cancers. Cancer Lett. 2006;244:53–60.
doi: 10.1016/j.canlet.2005.11.036
Saze Z, Terashima M, Kogure M, Ohsuka F, Suzuki H, Gotoh M. Activation of the sonic hedgehog pathway and its prognostic impact in patients with gastric cancer. Dig Surg. 2012;29:115–23.
doi: 10.1159/000336949
Noman AS, Uddin M, Rahman MZ, Nayeem MJ, Alam SS, Khatun Z, et al. Overexpression of sonic hedgehog in the triple negative breast cancer: clinicopathological characteristics of high burden breast cancer patients from Bangladesh. Sci Rep. 2016;6:18830.
doi: 10.1038/srep18830
Noman AS, Uddin M, Chowdhury AA, Nayeem MJ, Raihan Z, Rashid MI, et al. Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer. Sci Rep. 2017;7:1796.
doi: 10.1038/s41598-017-01268-4
Wan ES, Li Y, Lao T, Qiu W, Jiang Z, Mancini JD, et al. Metabolomic profiling in a Hedgehog Interacting Protein (Hhip) murine model of chronic obstructive pulmonary disease. Sci Rep. 2017;7:2504.
doi: 10.1038/s41598-017-02701-4
Kim WJ, Lee SD. Candidate genes for COPD: current evidence and research. Int J Chron Obstruct Pulmon Dis. 2015;10:2249–55.
pubmed: 26527870
pmcid: 4621177
Cao X, Wen ZS, Wang XD, Li Y, Liu KY, Wang X. The clinical effect of metformin on the survival of lung cancer patients with diabetes: a comprehensive systematic review and meta-analysis of retrospective studies. J Cancer. 2017;8:2532–41.
doi: 10.7150/jca.19750
Ekström MP. The rise and fall of COPD mortality. Lancet Respir Med. 2014;2:4–6.
doi: 10.1016/S2213-2600(13)70257-1
Ziolkowska-Suchanek I, Mosor M, Gabryel P, Grabicki M, Zurawek M, Fichna M, et al. Susceptibility loci in lung cancer and COPD: association of IREB2 and FAM13A with pulmonary diseases. Sci Rep. 2015;5:13502.
doi: 10.1038/srep13502
Nakamura H. Genetics of COPD. Allergol Int. 2011;60:253–8.
doi: 10.2332/allergolint.11-RAI-0326
Lee PN, Fry JS, Forey BA. Estimating the decline in excess risk of chronic obstructive pulmonary disease following quitting smoking - a systematic review based on the negative exponential model. Regul Toxicol Pharmacol. 2014;68:231–9.
doi: 10.1016/j.yrtph.2013.12.006
Soler Artigas M, Wain LV, Repapi E, Obeidat M, Sayers I, Burton PR, et al. Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function. Am J Respir Crit Care Med. 2011;184:786–95.
doi: 10.1164/rccm.201102-0192OC